Ras

Ras inhibitors and related small GTPase modulators act on KRAS and on the Rac, Rho and Cdc42 proteins. Small GTPases of the Ras superfamily work as molecular switches. They cycle between an active form bound to guanosine triphosphate (GTP) and an inactive form bound to guanosine diphosphate (GDP). Oncogenic KRAS mutations such as G12C keep the protein in its signaling state. ARS-853 and KRas G12C inhibitor 4 target the mutant cysteine of KRAS G12C, while Kobe2602 interferes with binding of Ras to Raf. Salirasib, a farnesylcysteine mimetic, disrupts the membrane association of Ras. Rho-family tools include NSC 23766 and EHT 1864, which inhibit Rac, and CASIN, which targets Cdc42.

Items 26-50 of 362

  • 6H05
    Cat. No.
    A16097

    6H05

    Synonyms: K-Ras inhibitor

    6H05 is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C).

    5 mg
    $120.00
    10 mg
    $220.00
    All 4 sizes
  • APS-2-79 HCl
    Cat. No.
    A16175

    APS-2-79 HCl

    Synonyms: KSR/Ras Inhibitor

    APS-2-79 HCl, small molecule that stabilizes the KSR (Kinase suppressor of Ras) inactive state and antagonizes oncogenic Ras signalling (IC50 value 120 nM against ATP-biotin probe-labelling of KSR2).

    1 mg
    $30.00
    2 mg
    $45.00
    All 9 sizes
  • Adagrasib
    Cat. No.
    A16482

    Adagrasib (MRTX849)

    Synonyms: MRTX 849

    Adagrasib (MRTX849) is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity.

    5 mg
    $50.00
    10 mg
    $85.00
    All 7 sizes
  • ML141
    Cat. No.
    A16621

    ML141

    Synonyms: CID-2950007

    ML141 (CID-2950007) is a potent, allosteric, selective and reversible non-competitive inhibitor of Cdc42 GTPase. ML141 inhibits Cdc42 wild type and Cdc42 Q61L mutant with EC50s of 2.1 and 2.6 μM, respectively. ML141 shows low micromolar potency and selectivity against other members of the Rho family of GTPases (Rac1, Rab2, Rab7). ML141 do not show cytotoxicity in multiple cell lines.

    1 mg
    $25.00
    2 mg
    $40.00
    All 7 sizes
  • RBC8
    Cat. No.
    A16681

    RBC8

    RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell.

    1 mg
    $35.00
    5 mg
    $85.00
    All 8 sizes
  • MBQ-167
    Cat. No.
    A16808

    MBQ-167

    MBQ-167 is a potent and dual inhibitor of Rac and Cdc42 with IC50s of 103 nM and 78 nM respectively, in metastatic breast cancer cells.

    1 mg
    $25.00
    2 mg
    $35.00
    All 8 sizes
  • ARS-1620
    Cat. No.
    A16809

    ARS-1620

    ARS-1620 is a potent, orally bioavailable covalent inhibitor of KRAS-G12C) and could achieve rapid and sustained in vivo target occupancy to induce tumor regression.

    1 mg
    $75.00
    2 mg
    $110.00
    All 8 sizes
  • BDP9066
    Cat. No.
    A16874

    BDP9066

    BDP9066 is a potent and selective MRCK inhibitor, reducing substrate phosphorylation.

    1 mg
    $45.00
    2 mg
    $80.00
    All 9 sizes
  • CCG-203971
    Cat. No.
    A16928

    CCG-203971

    CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50 = 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

    5 mg
    $30.00
    10 mg
    $40.00
    All 7 sizes
  • 1A-116
    Cat. No.
    A16965

    1A-116

    1A-116 is a specific Rac1 inhibitor, can prevent EGF-induced Rac1 activation and block Rac1-P-Rex1 interaction. 1A-116 can induce apoptosis and inhibit cell proliferation, migration and cycle progression in a concentration-dependent manner. 1A-116 also demonstrates a high antimetastatic activity in vivo.

    1 mg
    $40.00
    5 mg
    $105.00
    All 8 sizes
  • BDP5290
    Cat. No.
    A16966

    BDP5290

    BDP5290 is a potent inhibitor of both ROCK and MRCK with IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.

    1 mg
    $45.00
    2 mg
    $65.00
    All 8 sizes
  • Antineoplaston A10
    Cat. No.
    A17183

    Antineoplaston A10

    Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer.

    2 mg
    $30.00
    5 mg
    $60.00
    All 8 sizes
  • Ras-IN-3144
    Cat. No.
    A17222

    Ras-IN-3144

    Synonyms: 3144; pan-RAS inhibitor-3144

    Ras-IN-3144 is a pan-RAS inhibitor which inhibits RAS signaling pathways in cancer cells and prevents the growth of RAS mutant mouse cancer xenografts.

    1 mg
    $65.00
    2 mg
    $90.00
    All 9 sizes
  • MRTX1257
    Cat. No.
    A17223

    MRTX1257

    MRTX1257 is a potent, selective, covalent and irreversible inhibitor of KRAS G12C, MRTX1257 inhibited KRAS dependent ERKphosphorylation in the H358cell assay with an IC50= 900 pM.

    1 mg
    $50.00
    2 mg
    $75.00
    All 8 sizes
  • BAY 293
    Cat. No.
    A18319

    BAY 293

    BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 21 nM.

    1 mg
    $40.00
    5 mg
    $105.00
    All 7 sizes
  • ZT-12-037-01
    Cat. No.
    A18395

    ZT-12-037-01

    ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor. ZT-12-037-01 effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vitro and in vivo.

    1 mg
    $25.00
    5 mg
    $60.00
    All 7 sizes
  • KRAS G12C inhibitor 17
    Cat. No.
    A18441

    KRAS G12C inhibitor 17

    KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 82, has an IC50 of 5 nM.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • KRAS G12C inhibitor 16
    Cat. No.
    A18444

    KRAS G12C inhibitor 16

    KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM.

    1 mg
    $315.00
    2 mg
    $600.00
    All 6 sizes
  • KRAS G12C inhibitor 15
    Cat. No.
    A18447

    KRAS G12C inhibitor 15

    KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 22, has an IC50 of 5 nM.

    1 mg
    $315.00
    5 mg
    $915.00
    All 6 sizes
  • PHT-7.3
    Cat. No.
    A18473

    PHT-7.3

    PHT-7.3 is a selective inhibitor of connector enhancer of kinase suppressor of Ras 1 (Cnk1) pleckstrin homology (PH) domain, which inhibits mut-KRas, but not wild-type KRas cancer cell and tumor growth and signaling.

    5 mg
    $215.00
    10 mg
    $360.00
    All 6 sizes
  • AMG-510 racemate
    Cat. No.
    A18752

    AMG-510 racemate

    Synonyms: AMG 510

    AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.

    2 mg
    $25.00
    5 mg
    $40.00
    All 7 sizes
  • Sotorasib
    Cat. No.
    A19021

    Sotorasib (AMG-510)

    Synonyms: AMG 510

    AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.

    1 mg
    $25.00
    2 mg
    $35.00
    All 10 sizes

Items 26-50 of 362

Added to your cart

View Cart Checkout

    Loading...